1. Home
  2. YELP vs IMTX Comparison

YELP vs IMTX Comparison

Compare YELP & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yelp Inc.

YELP

Yelp Inc.

HOLD

Current Price

$26.52

Market Cap

1.2B

ML Signal

HOLD

Logo Immatics N.V.

IMTX

Immatics N.V.

HOLD

Current Price

$9.24

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YELP
IMTX
Founded
2004
N/A
Country
United States
Germany
Employees
N/A
407
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.4B
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
YELP
IMTX
Price
$26.52
$9.24
Analyst Decision
Hold
Strong Buy
Analyst Count
6
6
Target Price
$29.17
$19.00
AVG Volume (30 Days)
1.3M
345.9K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
19.15
N/A
EPS
0.30
N/A
Revenue
$1,464,955,000.00
N/A
Revenue This Year
$2.19
N/A
Revenue Next Year
$2.34
$25.91
P/E Ratio
$87.77
N/A
Revenue Growth
3.75
N/A
52 Week Low
$19.60
$5.05
52 Week High
$35.26
$12.41

Technical Indicators

Market Signals
Indicator
YELP
IMTX
Relative Strength Index (RSI) 56.82 41.01
Support Level $23.85 $8.98
Resistance Level $27.23 $10.67
Average True Range (ATR) 1.02 0.52
MACD 0.09 -0.02
Stochastic Oscillator 61.33 7.28

Price Performance

Historical Comparison
YELP
IMTX

About YELP Yelp Inc.

Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making appropriate buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States, and also has its presence in other countries.

About IMTX Immatics N.V.

Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Share on Social Networks: